CYP2C19 genotype-directed P2Y12 inhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention oleh Tomasz P. Stys, Maheedhar Gedela, Smitha N. Gowda, Valerie Bares, Lauren Fanta, Marian Petrasko, Catherine Hajek, Eric Larson, Adam T. Stys